What is FUJIFILM Holdings Corporation (FUJIY)?

FUJIFILM Holdings Corporation (FUJIY) is a stock in the Industrials sector, Conglomerates industry. View full analysis on Stocks360.

What is the current price of FUJIY?

The current price of FUJIY is $10.37. Prices are updated in real time on Stocks360.

What is FUJIY's price-to-earnings (PE) ratio?

FUJIY's trailing twelve-month PE ratio is 15.07, based on current price and earnings per share data available on Stocks360.

What is FUJIY's market capitalization?

FUJIY's market capitalization is $24,804,777,577.00, placing it in the large-cap tier.

Does FUJIY pay a dividend?

Yes. FUJIY has a trailing twelve-month dividend yield of 0.02%. Dividend data is sourced from financial market providers and displayed on Stocks360.

FUJIFILM Holdings Corporation (FUJIY)

Stock analysis · OTC · Industrials · Conglomerates

$10.37

Market Cap

$24.80B

PE (TTM)

15.07

EPS (TTM)

N/A

Dividend Yield

2.15%

Beta

0.39

Day Range

$10.36 – $10.45

52-wk Range

$8.93 – $12.99

Avg Volume

N/A

Volume

8.93K

FUJIFILM Holdings Corporation (FUJIY) is a publicly traded company in the Industrials sector. Latest price: $10.37. Market cap $24.80B. Trailing PE 15.07. Dividend yield 2.15%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-09-16 · $12.51 2026-09-15 · $10.37 (-17.11%)

Earnings

Most Recent

Aug 6, 2026

EPS $0.10 vs est. $0.16

Missed by $0.06

Next Earnings

Nov 5, 2026

EPS estimate $0.17

Proprietary Signals

Signal snapshot temporarily unavailable.

About FUJIFILM Holdings Corporation

FUJIFILM Holdings Corporation, trading as FUJIY, is a global conglomerate that designs, produces, markets, and supports a wide range of solutions across imaging, healthcare, advanced materials, and business innovation sectors. The company was founded in 1934 and maintains its headquarters in Tokyo, Japan. Its Healthcare division provides an extensive suite of products and services geared towards prevention, diagnosis, and treatment. These offerings include state-of-the-art medical devices, specialized biomedical contract development and manufacturing organization (CDMO) services, pharmaceuticals, regenerative medicines, and various cosmetics and nutritional supplements. The Materials segment delivers crucial components and systems for industrial applications. This includes digital inkjet presses, printing plates, and related industrial inkjet products like inkjet heads for the printing industry. It also offers robust storage media and comprehensive archiving services for the management of large digital data volumes. Furthermore, this segment supplies a variety of industrial-grade materials for critical technologies such as displays, touch panels, semiconductors, image sensors, and…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	15.07×
P/S (TTM)	1.14×
P/B	1.00×
PEG	5.81×
P/FCF (TTM)	-38.49×
EV / EBITDA	10.10×
EV / Sales	1.41×
Earnings Yield	6.68%
Free Cash Flow Yield	-2.60%
Dividend Yield	2.15%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$4.86T
Revenue (TTM)	$3.43T
Net Income (TTM)	$260.43B
Free Cash Flow (TTM)	-$146.73B
Net Debt	$959.71B
Working Capital	$462.35B
Gross Margin	40.20%
Operating Margin	9.50%
Net Margin	7.58%
Return on Equity	6.97%
Return on Invested Capital	4.67%